RecruitingEarly Phase 1NCT06633354

Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Zhejiang University
Principal Investigator
He Huang, MD
First Affiliated Hospital of Zhejiang University
Intervention
CD5 CAR T-cells(biological)
Enrollment
30 enrolled
Eligibility
All sexes
Timeline
20242027

Study locations (1)

Collaborators

Yake Biotechnology Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06633354 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials